OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Anti-Infective Therapy is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	131
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	111
Challenges in preserving antibiotic effectiveness: time for a novel approach	87
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	55
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	51
Neonatal ocular prophylaxis in the United States: is it still necessary?	51
Visceral leishmaniasis elimination in India: progress and the road ahead	47
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	47
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	41
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	39
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	34
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	34
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	34
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	34
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	31
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	31
Reemergence of monkeypox: prevention and management	31
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	30
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	29
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	28
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	27
Identifying predictors of treatment failure with community-acquired pneumonia: an update	26
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?	26

Treatment of vaginitis caused by non-albicans Candida species